Our study identified a correlation between ALDH1A1 and S100A4 with up-regulated immune and metabolic pathways in the resistant subgroup, alongside the enrichment of certain tumor and glucose metabolism-related pathways. The gene discussed is ALDH1A1; the disease is neoplasm.